CN Patent

CN102413687A — 静脉注射布洛芬的施用

Assigned to Cumberland Pharmaceuticals Inc · Expires 2012-04-11 · 14y expired

What this patent protects

对外科手术患者每6小时施用静脉注射布洛芬的有效剂量是降低疼痛和对吗啡需求的安全且有效的方法。在优选的实施方案中，在麻醉的起始开始静脉注射布洛芬的施用。

USPTO Abstract

对外科手术患者每6小时施用静脉注射布洛芬的有效剂量是降低疼痛和对吗啡需求的安全且有效的方法。在优选的实施方案中，在麻醉的起始开始静脉注射布洛芬的施用。

Drugs covered by this patent

Patent Metadata

Patent number: CN102413687A
Jurisdiction: CN
Classification: —
Expires: 2012-04-11
Drug substance claim: No
Drug product claim: No
Assignee: Cumberland Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.